Literature DB >> 27358875

Shp2 regulates leukemic stem cell frequency in MLL-rearranged acute myeloid leukemia.

Jie Wu1.   

Abstract

Entities:  

Year:  2015        PMID： 27358875      PMCID： PMC4923662          DOI： 10.3978/j.issn.2306-9759.2015.04.01

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


× No keyword cloud information.
  5 in total

Review 1.  The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.

Authors:  B V Balgobind; C M Zwaan; R Pieters; M M Van den Heuvel-Eibrink
Journal:  Leukemia       Date:  2011-05-13       Impact factor: 11.528

2.  Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.

Authors:  Gordon Chan; Demetrios Kalaitzidis; Tatiana Usenko; Jeffery L Kutok; Wentian Yang; M Golam Mohi; Benjamin G Neel
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

3.  Somatic PTPN11 mutations in childhood acute myeloid leukaemia.

Authors:  Marco Tartaglia; Simone Martinelli; Ivano Iavarone; Giovanni Cazzaniga; Monica Spinelli; Emanuela Giarin; Valentina Petrangeli; Claudio Carta; Riccardo Masetti; Maurizio Aricò; Franco Locatelli; Giuseppe Basso; Mariella Sorcini; Andrea Pession; Andrea Biondi
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

4.  Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.

Authors:  Dan Xu; Xia Liu; Wen-Mei Yu; Howard J Meyerson; Caiying Guo; Stanton L Gerson; Cheng-Kui Qu
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307

5.  Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.

Authors:  L Chen; W Chen; M Mysliwski; J Serio; J Ropa; F A Abulwerdi; R J Chan; J P Patel; M S Tallman; E Paietta; A Melnick; R L Levine; O Abdel-Wahab; Z Nikolovska-Coleska; A G Muntean
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.